
Sign up to save your podcasts
Or
David Perry, chairman and co-founder of Better Therapeutics, spoke with Let’s Talk Medtech about the company’s efforts and going public through a Special Purpose Acquisition Corporation Merger (SPAC).
4.9
77 ratings
David Perry, chairman and co-founder of Better Therapeutics, spoke with Let’s Talk Medtech about the company’s efforts and going public through a Special Purpose Acquisition Corporation Merger (SPAC).
30,900 Listeners
510 Listeners
58 Listeners
111,501 Listeners
56,177 Listeners
8,723 Listeners
23 Listeners
5,337 Listeners
3,834 Listeners